Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-04

Clinical Trial Update: Neurofeedback to Treat Depression - 2 [NA]

View source ↗

Summary

University of Pennsylvania-sponsored clinical trial evaluating neurofeedback as a treatment for major depressive disorder, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neurofeedback Therapy

Snippet

Sponsor: University of Pennsylvania | Conditions: Major Depressive Disorder (MDD) | NA | Status: RECRUITING